| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | INTRALINKS HLDGS INC | 347,032 | 2,877,000 | 0.14% | ||
| 102 | CEMPRA INC | 100,000 | 2,784,000 | 0.13% | Put | |
| 103 | MEDIWOUND ORD | 313,500 | 2,392,000 | 0.12% | ||
| 104 | JAGUAR ANIMAL HEALTH INC | 699,831 | 2,267,000 | 0.11% | ||
| 105 | Otonomy Inc | 110,000 | 1,959,000 | 0.09% | ||
| 106 | NUVASIVE INC | 40,500 | 1,953,000 | 0.09% | ||
| 107 | CLOVIS ONCOLOGY INC | 20,600 | 1,894,000 | 0.09% | ||
| 108 | CYMABAY THERAPEUTICS INC | 950,000 | 1,843,000 | 0.09% | ||
| 109 | SYNERGY PHARMACEUTICALS DEL | 340,000 | 1,802,000 | 0.09% | ||
| 110 | OVASCIENCE INC COM | 200,000 | 1,698,000 | 0.08% | Call | |
| 111 | CIVITAS SOLUTIONS INC | 74,050 | 1,697,000 | 0.08% | ||
| 112 | UNIVERSAL HLTH SVCS INC | 13,100 | 1,635,000 | 0.08% | ||
| 113 | SunEdison Inc | 225,000 | 1,616,000 | 0.08% | ||
| 114 | INTRA-CELLULAR THERAPIES INC | 40,000 | 1,602,000 | 0.08% | ||
| 115 | AEGERION PHARMACEUTICALS INC | 2,000,000 | 1,509,000 | 0.07% | PRN | |
| 116 | REPROS THERAPEUTICS INC | 200,000 | 1,486,000 | 0.07% | Call | |
| 117 | CEMPRA INC | 50,000 | 1,392,000 | 0.07% | ||
| 118 | APPLE INC | 11,252 | 1,241,000 | 0.06% | ||
| 119 | QLIK TECHNOLOGIES INC COM | 32,359 | 1,179,000 | 0.06% | ||
| 120 | INOTEK PHARMACEUTICALS CORP | 115,000 | 1,081,000 | 0.05% | ||
| 121 | TETRALOGIC PHARMACEUTICALS C | 2,000,000 | 1,051,000 | 0.05% | PRN | |
| 122 | E TRADE FINANCIAL CORP | 39,570 | 1,042,000 | 0.05% | ||
| 123 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 20,200 | 852,000 | 0.04% | ||
| 124 | AMERICAN AIRLS GROUP INC | 450,000 | 608,000 | 0.03% | ||
| 125 | EXELIXIS INC | 100,000 | 561,000 | 0.03% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-15-008246, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
